Guru Ownership Trend
Guru Analysis for Syndax Pharmaceuticals, Inc. (SNDX)
Syndax Pharmaceuticals, Inc. (SNDX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.84 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bearish. This is evidenced by a $52.8 M net outflow during the quarter.
Recent activity highlights John Hussman who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 35.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Syndax Pharmaceuticals, Inc. (SNDX)
Major holders include Cliff Asness ($18.65 M), Renaissance Technologies (RenTech) ($7.03 M), John Hussman ($1.84 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.26 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $52.8 M, with 1 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited SNDX. The total reported sell value was $54.63 M.
Yes, 1 managers opened new positions in SNDX, and 0 increased their existing holdings. The total reported buy value was $1.84 M.